StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
H.C. Wainwright Reiterates Buy Rating on MannKind (MNKD)
August 6, 2026 6:57 AM
H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating and $10.00 price target on MannKind (NASDAQ: MNKD).The analyst commented: "FDA ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
